Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvalent Inc | 17,248,450 | 17,248,450 | 0 | $1.77B | $2.13B | 22.22% | +$363.08M |
| Brookdale Senior Living Inc.NOTE 3 500 10 1(BKD) | 0 | 0 | 0 | $505.44M | $585.70M | 6.11% | +$80.26M |
| Revolution Medicines, Inc.(RVMD) | 2,297,000 | 2,392,000 | +95,000 | $223.38M | $447.97M | 4.67% | +$224.59M |
| Praxis Precision Medicines, Inc.(PRAX) | 963,351 | 963,351 | 0 | $310.38M | $322.52M | 3.36% | +$12.14M |
| Viatris Inc.(VTRS) | 20,206,170 | 20,206,170 | 0 | $272.99M | $320.87M | 3.35% | +$47.89M |
| Centene Corporation(CNC) | 5,917,091 | 4,901,000 | -1,016,091 | $193.73M | $314.60M | 3.28% | +$120.87M |
| Revolution Medicines IncNOTE 0 500 5 0 | 0 | 0 | 0 | $0 | $251.68M | 2.63% | +$251.68M |
| United Therapeutics Corporation(UTHR) | 457,000 | 457,000 | 0 | $270.99M | $247.62M | 2.58% | -$23.38M |
| Arrowhead Pharmaceuticals, Inc.NOTE 1 1(ARWR) | 0 | 0 | 0 | $207.18M | $240.54M | 2.51% | +$33.36M |
| Legend Biotech CorporationADS(LEGN) | 7,687,638 | 8,137,638 | +450,000 | $139.07M | $235.01M | 2.45% | +$95.95M |
| Cogent Biosciences, Inc.(COGT) | 9,043,903 | 5,006,104 | -4,037,799 | $348.10M | $193.74M | 2.02% | -$154.36M |
| Genmab A/SADS(GMAB) | 2,462,000 | 6,865,000 | +4,403,000 | $66.06M | $188.58M | 1.97% | +$122.53M |
| Brookdale Senior Living Inc.(BKD) | 11,637,032 | 11,637,032 | 0 | $159.19M | $187.24M | 1.95% | +$28.05M |
| Vera Therapeutics, Inc.CL A(VERA) | 3,722,100 | 3,916,400 | +194,300 | $149.74M | $168.05M | 1.75% | +$18.31M |
| Ionis Pharmaceuticals, Inc.(IONS) | 1,979,669 | 1,979,669 | 0 | $148.65M | $156.97M | 1.64% | +$8.31M |
| Celcuity Inc.(CELC) | 1,714,000 | 1,451,014 | -262,986 | $195.64M | $151.81M | 1.58% | -$43.83M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 15,038,000 | 15,096,403 | +58,403 | $143.16M | $150.96M | 1.57% | +$7.80M |
| Newamsterdam Pharma Company ORDINARY SHARES | 4,264,789 | 4,264,789 | 0 | $136.52M | $144.53M | 1.51% | +$8.02M |
| Acadia Healthcare Company, Inc.(ACHC) | 4,520,000 | 4,520,000 | 0 | $105.72M | $133.48M | 1.39% | +$27.75M |
| Tango Therapeutics, Inc.(TNGX) | 4,146,813 | 4,190,611 | +43,798 | $86.75M | $131.00M | 1.37% | +$44.25M |
| AdaptHealth Corp.(AHCO) | 11,477,730 | 11,477,730 | 0 | $136.58M | $119.60M | 1.25% | -$16.99M |
| Pharvaris N V COM | 3,126,042 | 3,376,042 | +250,000 | $88.31M | $116.74M | 1.22% | +$28.43M |
| Celcuity IncNOTE 0 250 8 0 | 0 | 0 | 0 | $0 | $113.78M | 1.19% | +$113.78M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 1,573,297 | 1,389,055 | -184,242 | $98.65M | $113.22M | 1.18% | +$14.58M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,019,813 | 1,125,313 | +105,500 | $85.58M | $109.70M | 1.14% | +$24.11M |
| Larimar Therapeutics, Inc.(LRMR) | 35,606,974 | 35,606,974 | 0 | $160.23M | $108.60M | 1.13% | -$51.63M |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 3,958,000 | +3,958,000 | $0 | $106.79M | 1.11% | +$106.79M |
| Alignment Healthcare, Inc.NOTE 4 250 11 1(ALHC) | 0 | 0 | 0 | $85.86M | $103.83M | 1.08% | +$17.97M |
| IDEAYA Biosciences, Inc.(IDYA) | 1,530,008 | 2,714,503 | +1,184,495 | $50.98M | $101.17M | 1.06% | +$50.19M |
| Xenon Pharmaceuticals Inc.(XENE) | 1,615,696 | 1,615,696 | 0 | $93.95M | $97.52M | 1.02% | +$3.57M |
| Ionis Pharmaceuticals, Inc.NOTE 1 750 6 1(IONS) | 0 | 0 | 0 | $90.61M | $93.10M | 0.97% | +$2.49M |
| Savara Inc.(SVRA) | 13,569,000 | 13,569,000 | 0 | $74.09M | $83.59M | 0.87% | +$9.50M |
| Lantheus Holdings, Inc.(LNTH) | 827,999 | 752,999 | -75,000 | $62.80M | $83.54M | 0.87% | +$20.73M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 3,779,900 | 3,779,900 | 0 | $88.30M | $82.63M | 0.86% | -$5.67M |
| Zenas BioPharma, Inc.NOTE 2 500 4 0(ZBIO) | 0 | 0 | 0 | $67.25M | $80.32M | 0.84% | +$13.06M |
| BioMarin Pharmaceutical Inc.(BMRN) | 851,556 | 1,332,836 | +481,280 | $48.10M | $76.26M | 0.80% | +$28.16M |
| Pfizer Inc.(PFE) | 3,040,000 | 3,040,000 | 0 | $85.36M | $73.20M | 0.76% | -$12.16M |
| Indivior Pharmaceuticals, Inc.(INDV) | 3,097,790 | 1,648,895 | -1,448,895 | $94.42M | $67.65M | 0.71% | -$26.77M |
| Bio Rad Labs IncCL A | 226,070 | 226,070 | 0 | $63.02M | $66.38M | 0.69% | +$3.36M |
| ARS Pharmaceuticals, Inc.(SPRY) | 7,503,812 | 7,503,812 | 0 | $60.26M | $60.11M | 0.63% | -$150.1K |
| Stoke Therapeutics, Inc.(STOK) | 1,823,500 | 1,823,500 | 0 | $59.37M | $59.66M | 0.62% | +$291.8K |
| Structure Therapeutics IncADS | 767,993 | 1,086,000 | +318,007 | $37.02M | $58.29M | 0.61% | +$21.27M |
| Envista Holdings Corporation(NVST) | 2,210,100 | 2,210,100 | 0 | $56.07M | $58.24M | 0.61% | +$2.17M |
| Inspire Medical Systems, Inc.(INSP) | 2,703,238 | 1,296,862 | -1,406,376 | $139.43M | $57.85M | 0.60% | -$81.58M |
| CareDx, Inc.(CDNA) | 2,191,000 | 1,997,618 | -193,382 | $38.04M | $56.93M | 0.59% | +$18.90M |
| Boston Scientific Corporation(BSX) | 0 | 1,315,000 | +1,315,000 | $0 | $56.12M | 0.59% | +$56.12M |
| Belite Bio, IncADS(BLTE) | 304,013 | 357,199 | +53,186 | $48.47M | $55.00M | 0.57% | +$6.53M |
| Parabilis Medicines Inc | 0 | 1,880,704 | +1,880,704 | $0 | $51.47M | 0.54% | +$51.47M |
| Certara, Inc.(CERT) | 7,808,605 | 7,512,928 | -295,677 | $44.51M | $49.21M | 0.51% | +$4.70M |
| Disc Medicine, Inc.(IRON) | 657,000 | 657,000 | 0 | $42.01M | $48.05M | 0.50% | +$6.04M |
| LivaNova PLCNOTE 2 500 3 1(LIVN) | 0 | 0 | 0 | $40.03M | $46.49M | 0.48% | +$6.45M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 4,885,446 | 4,885,446 | 0 | $43.72M | $37.23M | 0.39% | -$6.50M |
| Tyra Biosciences, Inc.(TYRA) | 549,000 | 1,017,000 | +468,000 | $21.03M | $32.48M | 0.34% | +$11.46M |
| Monopar Therapeutics Inc.(MNPR) | 323,745 | 323,745 | 0 | $17.74M | $29.98M | 0.31% | +$12.24M |
| Sionna Therapeutics, Inc.(SION) | 970,590 | 680,916 | -289,674 | $38.91M | $29.95M | 0.31% | -$8.96M |
| Immunocore Holdings plcNOTE 2 500 2 0(IMCR) | 0 | 0 | 0 | $27.03M | $27.10M | 0.28% | +$79.1K |
| Avalyn Pharmaceuticals Inc | 0 | 731,000 | +731,000 | $0 | $24.06M | 0.25% | +$24.06M |
| Foghorn Therapeutics Inc.(FHTX) | 4,394,367 | 4,394,367 | 0 | $21.01M | $21.44M | 0.22% | +$439.4K |
| Beta Bionics, Inc.(BBNX) | 1,324,000 | 1,324,000 | 0 | $13.27M | $20.75M | 0.22% | +$7.48M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 67,935 | 67,935 | 0 | $22.48M | $20.45M | 0.21% | -$2.03M |
| Bright Minds Biosciences Inc.(DRUG) | 283,000 | 283,000 | 0 | $20.65M | $19.87M | 0.21% | -$783.9K |
| Odyssey Therapeutics Inc | 0 | 1,046,139 | +1,046,139 | $0 | $19.57M | 0.20% | +$19.57M |
| DFP Healthcare Acquisitions Cor(DFPH) | 3,360,052 | 3,360,052 | 0 | $10.32M | $18.25M | 0.19% | +$7.93M |
| Kyverna Therapeutics, Inc.(KYTX) | 2,000,000 | 2,000,000 | 0 | $17.26M | $17.82M | 0.19% | +$560.0K |
| Alamar Biosciences Inc | 0 | 600,000 | +600,000 | $0 | $16.25M | 0.17% | +$16.25M |
| Chemed Corporation(CHE) | 0 | 30,000 | +30,000 | $0 | $13.97M | 0.15% | +$13.97M |
| SpyGlass Pharma, Inc.(SGP) | 550,000 | 550,000 | 0 | $14.25M | $12.24M | 0.13% | -$2.01M |
| NeoGenomics, Inc.NOTE 0 250 1 1(NEO) | 0 | 0 | 0 | $66.65M | $12.20M | 0.13% | -$54.45M |
| Adagene IncADS | 0 | 2,666,666 | +2,666,666 | $0 | $11.20M | 0.12% | +$11.20M |
| Hemab Therapeutics Hldgs Inc | 0 | 275,000 | +275,000 | $0 | $10.10M | 0.11% | +$10.10M |
| Mobia Med Inc | 0 | 670,752 | +670,752 | $0 | $8.99M | 0.09% | +$8.99M |
| Embecta Corp.(EMBC) | 2,534,961 | 2,534,961 | 0 | $22.41M | $8.26M | 0.09% | -$14.15M |
| Veracyte, Inc.(VCYT) | 726,000 | 101,000 | -625,000 | $23.38M | $5.93M | 0.06% | -$17.45M |
| Annexon, Inc.(ANNX) | 583,913 | 583,913 | 0 | $3.23M | $3.33M | 0.03% | +$99.3K |
| Alector Inc | 1,055,192 | 1,055,192 | 0 | $2.27M | $2.12M | 0.02% | -$147.7K |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 92,787 | 92,787 | 0 | $1.86M | $1.98M | 0.02% | +$123.4K |
| Edwards Lifesciences Corp | 13,702 | 13,702 | 0 | $1.10M | $1.24M | 0.01% | +$142.2K |
| Mirum Pharmaceuticals, Inc.(MIRM) | 0 | 6,027 | +6,027 | $0 | $705.6K | 0.01% | +$705.6K |
| Humana Inc.(HUM) | 917 | 917 | 0 | $159.0K | $364.3K | 0.00% | +$205.3K |
| DFP Healthcare Acquisitions CorW EXP 99 99 999(DFPH) | 1,250,000 | 1,250,000 | 0 | $54.8K | $51.0K | 0.00% | -$3.8K |
| PMV Pharmaceuticals, Inc.(PMVP) | 8,790 | 8,790 | 0 | $10.9K | $11.8K | 0.00% | +$879 |
| Surrozen, Inc.W EXP 08 01 203(SRZN) | 166,666 | 166,666 | 0 | $2.7K | $2.8K | 0.00% | +$83 |
| Tessera Defense and Homeland Security Inc.(HLSQ) | 131,272 | 0 | -131,272 | $492.8K | $0 | — | -$492.8K |
| Catalyst Pharmaceuticals Inc | 3,943,600 | 0 | -3,943,600 | $97.64M | $0 | — | -$97.64M |
| Compass Therapeutics, Inc.(CMPX) | 3,606,000 | 0 | -3,606,000 | $19.08M | $0 | — | -$19.08M |
| Cullinan Therapeutics, Inc.(CGEM) | 386,169 | 0 | -386,169 | $5.49M | $0 | — | -$5.49M |
| Day One Biopharmaceuticals I COM | 3,723,131 | 0 | -3,723,131 | $79.82M | $0 | — | -$79.82M |
| Enhabit Inc COM | 4,747,746 | 0 | -4,747,746 | $66.90M | $0 | — | -$66.90M |
| Kymera Therapeutics, Inc.(KYMR) | 561,170 | 0 | -561,170 | $46.74M | $0 | — | -$46.74M |
| Mirum Pharmaceuticals, Inc.NOTE 4 000 5 0(MIRM) | 0 | 0 | 0 | $209.44M | $0 | — | -$209.44M |
| Myriad Genetics, Inc.(MYGN) | 505 | 0 | -505 | $2.3K | $0 | — | -$2.3K |
| Neurocrine Biosciences, Inc.(NBIX) | 610,000 | 0 | -610,000 | $80.36M | $0 | — | -$80.36M |
| Quantum-Si incorporatedW EXP 06 10 202(QSI) | 333,333 | 0 | -333,333 | $36.2K | $0 | — | -$36.2K |
| Taysha Gene Therapies, Inc.(TSHA) | 2,722,165 | 0 | -2,722,165 | $12.17M | $0 | — | -$12.17M |
| Veradermics, Incorporated(MANE) | 5,000 | 0 | -5,000 | $315.8K | $0 | — | -$315.8K |